Novo Nordisk | Passifs Courants



Current Liabilities Changement Date
ANI Pharmaceuticals USD 201.82M 8.14M 2025-03
Aurora Cannabis CAD 149.81M 40.71M 2024-12
Bausch Health Companies USD 4.26B 2.5B 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Canopy Growth CAD 97.02M 184.27M 2024-12
Corcept Therapeutics USD 143.07M 2.29M 2025-03
Drreddys Laboratories INR 131.95B 2.65B 2024-12
Eli Lilly USD 30.07B 1.69B 2025-03
GlaxoSmithKline GBP 20.83B 866M 2025-03
Merck USD 25.17B 3.25B 2025-03
Novartis USD 28.69B 560M 2024-12
Novo Nordisk 236.12B 27.76B 2025-03
Novo Nordisk DKK 208.36B 20.45B 2024-09
Pacira USD 314.73M 4.81M 2025-03
Perrigo USD 1.07B 29.6M 2025-03
Prestige Brands USD 106.62M 4.08M 2025-03
Sanofi 32.22B 3.06B 2025-03
Supernus Pharmaceuticals USD 292.4M 889K 2024-12
Zoetis USD 3.38B 27M 2025-03



Novo Nordisk Passifs Courants - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.